These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 11207085

  • 21. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ, Petersen JR, Talleruphuus U, Møller ML, Ladefoged SD, Mehlsen J, Jensen HA.
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [Abstract] [Full Text] [Related]

  • 22. Effects of low-dose omega-3 fatty acid substitution in type-2 diabetes mellitus with special reference to oxidative stress--a prospective preliminary study.
    Jain S, Gaiha M, Bhattacharjee J, Anuradha S.
    J Assoc Physicians India; 2002 Aug; 50():1028-33. PubMed ID: 12421024
    [Abstract] [Full Text] [Related]

  • 23. Beneficial effect of omega-3 fatty acids on sirolimus- or everolimus-induced hypertriglyceridemia in heart transplant recipients.
    Celik S, Doesch A, Erbel C, Blessing E, Ammon K, Koch A, Katus HA, Dengler TJ.
    Transplantation; 2008 Jul 27; 86(2):245-50. PubMed ID: 18645486
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of valsartan, an angiotensin II receptor antagonist, in hypertension after renal transplantation: a randomized multicenter study.
    Andrés A, Morales E, Morales JM, Bosch I, Campo C, Ruilope LM, Valsartan in Renal Transplantation Group.
    Transplant Proc; 2006 Oct 27; 38(8):2419-23. PubMed ID: 17097955
    [Abstract] [Full Text] [Related]

  • 25. The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Ward NC, Wu JH, Clarke MW, Puddey IB, Burke V, Croft KD, Hodgson JM.
    J Hypertens; 2007 Jan 27; 25(1):227-34. PubMed ID: 17143195
    [Abstract] [Full Text] [Related]

  • 26. Effects of atorvastatin and omega-3 fatty acids on LDL subfractions and postprandial hyperlipemia in patients with combined hyperlipemia.
    Nordøy A, Hansen JB, Brox J, Svensson B.
    Nutr Metab Cardiovasc Dis; 2001 Feb 27; 11(1):7-16. PubMed ID: 11383326
    [Abstract] [Full Text] [Related]

  • 27. No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study.
    Fellström B, Abedini S, Holdaas H, Jardine AG, Staffler B, Gimpelewicz C, Assessment of Lescol in Renal Transplantation (ALERT) study group.
    Clin Transplant; 2006 Feb 27; 20(6):732-9. PubMed ID: 17100723
    [Abstract] [Full Text] [Related]

  • 28. Effect of n-3 fatty acids on heart rate variability and baroreflex sensitivity in middle-aged subjects.
    Geelen A, Zock PL, Swenne CA, Brouwer IA, Schouten EG, Katan MB.
    Am Heart J; 2003 Aug 27; 146(2):E4. PubMed ID: 12891211
    [Abstract] [Full Text] [Related]

  • 29. Reduced incidence of hypertension after heterotopic cardiac transplantation compared with orthotopic cardiac transplantation: evidence that excision of the native heart contributes to post-transplant hypertension.
    Taegtmeyer AB, Crook AM, Barton PJ, Banner NR.
    J Am Coll Cardiol; 2004 Sep 15; 44(6):1254-60. PubMed ID: 15364328
    [Abstract] [Full Text] [Related]

  • 30. Use of atorvastatin in hyperlipidemic hypertensive renal transplant recipients.
    Krmar RT, Ferraris JR, Ramirez JA, Sorroche P, Legal S, Cayssials A.
    Pediatr Nephrol; 2002 Jul 15; 17(7):540-3. PubMed ID: 12172771
    [Abstract] [Full Text] [Related]

  • 31. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F.
    Clin Ther; 2004 Sep 15; 26(9):1436-45. PubMed ID: 15531006
    [Abstract] [Full Text] [Related]

  • 32. Enalapril/amlodipine combination in cyclosporine-treated renal transplant recipients: a prospective randomized trial.
    Halimi JM, Giraudeau B, Buchler M, Al-Najjar A, Etienne I, Laouad I, Bruyère F, Lebranchu Y.
    Clin Transplant; 2007 Sep 15; 21(2):277-84. PubMed ID: 17425758
    [Abstract] [Full Text] [Related]

  • 33. Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial.
    Hamazaki K, Itomura M, Huan M, Nishizawa H, Sawazaki S, Tanouchi M, Watanabe S, Hamazaki T, Terasawa K, Yazawa K.
    Nutrition; 2005 Jun 15; 21(6):705-10. PubMed ID: 15925295
    [Abstract] [Full Text] [Related]

  • 34. [Antihypertensive effect and safety evaluation of vegetable drink with peptides derived from sardine protein hydrolysates on mild hypertensive, high-normal and normal blood pressure subjects].
    Kawasaki T, Jun CJ, Fukushima Y, Kegai K, Seki E, Osajima K, Itoh K, Matsui T, Matsumoto K.
    Fukuoka Igaku Zasshi; 2002 Oct 15; 93(10):208-18. PubMed ID: 12471719
    [Abstract] [Full Text] [Related]

  • 35. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
    Khan TA, Schnickel G, Ross D, Bastani S, Laks H, Esmailian F, Marelli D, Beygui R, Shemin R, Watson L, Vartapetian I, Ardehali A.
    J Thorac Cardiovasc Surg; 2009 Dec 15; 138(6):1417-24. PubMed ID: 19931670
    [Abstract] [Full Text] [Related]

  • 36. Renal function and blood pressure in heart transplant recipients treated with cyclosporine.
    Rottembourg J, Mattei MF, Cabrol A, Leger P, Aupetit B, Beaufils H, Gluckman JC, Pavie A, Gandjbakhch I, Cabrol C.
    J Heart Transplant; 1985 Dec 15; 4(4):404-8. PubMed ID: 3916515
    [Abstract] [Full Text] [Related]

  • 37. Omega-3 fatty acids-supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: a randomized and controlled study.
    Wang X, Li W, Li N, Li J.
    JPEN J Parenter Enteral Nutr; 2008 Dec 15; 32(3):236-41. PubMed ID: 18443134
    [Abstract] [Full Text] [Related]

  • 38. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison.
    Lee HY, Kang HJ, Koo BK, Oh BH, Heung-Sun K, Kim KS, Seo HS, Ro YM, Kang JH, Woong CJ, Joo SJ, Kim MH, Joon-Han S, Yoon J, Park SH, Jin-Ok J, Ju AK, Chong-Yun R, Yeon KJ, Park KM, Lim DK, Park SY, Amostar Study Investigators.
    Clin Ther; 2005 Jun 15; 27(6):728-39. PubMed ID: 16117979
    [Abstract] [Full Text] [Related]

  • 39. The antiproteinuric effect of losartan is systemic blood pressure dependent.
    Crowe AV, Howse M, Vinjamuri S, Kemp GJ, Williams PS.
    Nephrol Dial Transplant; 2003 Oct 15; 18(10):2160-4. PubMed ID: 13679496
    [Abstract] [Full Text] [Related]

  • 40. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep 15; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.